Systematic Review
Accepted on 28 Aug 2025
Efficacy and safety of IL-17, IL-12/23 and IL-23 Inhibitors for psoriatic arthritis: a network meta-analysis of randomized controlled trials
in Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders